What I was thinking as well Q, was that if there was positive trading update to announce with this they would have, surely? Yet no marketing update to sooth what is a horrible outcome.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%